On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...

Ahead of a planned trial next month, Jazz Pharmaceuticals is moving to resolve antitrust allegations surrounding its key ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

Ask a healthcare professional (HCP) to name a psychiatric medicine and chances are they’ll say a brand approved at least 10 ...

After the success of a public service advertisement campaign aimed at improving recognition of the early signs of Alzheimer’s disease ...

A New York City federal court has dismissed a proposed class action lawsuit against Bristol Myers Squibb that accused the ...

Mucinex maker Reckitt Beckiser’s new “simpler and more effective organization” won’t include 190 New Jersey workers. | ...

Although President Donald Trump’s “Liberation Day” tariffs have spared pharmaceuticals, potential drug-specific import taxes ...

Looking to cement its spot in the burgeoning realm of radiopharmaceuticals, Florida-based contract manufacturer PharmaLogic ...

Over the last few years, with fears increased in the healthcare industry that its top executives could be targets of violence ...

While the omission of pharmaceuticals from President Donald Trump’s much-anticipated reciprocal tariffs gave the industry a ...

Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics ...